Last updated at 12 Jan 2025 08:43 PM
Director
DIN: 08783852
Mohammad Nasim Akhter is currently associated with 2 companies as Director. They serve as a Director at BISMILLAH AGENCY PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08783852.Mohammad Nasim Akhter has previously been associated with 1 company in roles such as Additional Director.Mohammad Nasim Akhter is currently involved in 1 different role. Their most recent position is with SNAPCURE PHARMACEUTICAL PRIVATE LIMITED as a Director. The first company Mohammad Nasim Akhter was appointed to as a director was BISMILLAH AGENCY PRIVATE LIMITED. Mohammad Nasim Akhter is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Mohammad Nasim Akhter is currently associated with 2 companies as Director. They serve as a Director at BISMILLAH AGENCY PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08783852.Mohammad Nasim Akhter has previously been associated with 1 company in roles such as Additional Director.Mohammad Nasim Akhter is currently involved in 1 different role. Their most recent position is with SNAPCURE PHARMACEUTICAL PRIVATE LIMITED as a Director. The first company Mohammad Nasim Akhter was appointed to as a director was BISMILLAH AGENCY PRIVATE LIMITED. Mohammad Nasim Akhter is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (1)
1y 1m 7 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| BISMILLAH AGENCY PRIVATE LIMITED | Director | 30-Nov-2021 |
| SNAPCURE PHARMACEUTICAL PRIVATE LIMITED | Director | 30-Aug-2024 |